These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 15937208

  • 1. Patients undergoing coronary revascularisation: a missed opportunity for secondary prevention?
    Fox DJ, Kibiro M, Eichhöfer J, Curzen NP.
    Postgrad Med J; 2005 Jun; 81(956):401-3. PubMed ID: 15937208
    [Abstract] [Full Text] [Related]

  • 2. Use and cost of branded and generic drugs in patients with coronary heart disease--results from a prospective survey of 1008 patients in two London hospitals.
    Corp EV, Antoniou S, Wright PG, Khachi H, Vercaeren S, Wald DS.
    QJM; 2009 Dec; 102(12):843-9. PubMed ID: 19828644
    [Abstract] [Full Text] [Related]

  • 3. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up.
    Turley AJ, Roberts AP, Morley R, Thornley AR, Owens WA, de Belder MA.
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):231-4. PubMed ID: 18234766
    [Abstract] [Full Text] [Related]

  • 4. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS, Bajorek BV.
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry.
    Eisenberg MJ, Okrainec K, Lefkovits J, Goudreau E, Deligonul U, Mak KH, Duerr R, Tsang J, Huynh T, Sedlis S, Brown DL, Brieger D, Pilote L, ROSETTA Investigators.
    Can J Cardiol; 2003 Aug; 19(9):1009-15. PubMed ID: 12915928
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
    Maddox TM, Ho PM, Roe M, Dai D, Tsai TT, Rumsfeld JS.
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):632-41. PubMed ID: 20923997
    [Abstract] [Full Text] [Related]

  • 11. Use of evidence-based management for acute coronary syndrome.
    Tang E, Wong CK, Wilkins G, Herbison P, Williams M, Kay P, Restieaux N.
    N Z Med J; 2005 Oct 07; 118(1223):U1678. PubMed ID: 16224502
    [Abstract] [Full Text] [Related]

  • 12. Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention.
    Hlatky MA, Solomon MD, Shilane D, Leong TK, Brindis R, Go AS.
    J Am Coll Cardiol; 2013 Jan 22; 61(3):295-301. PubMed ID: 23246391
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG.
    Am J Med; 2004 Jul 15; 117(2):73-81. PubMed ID: 15234641
    [Abstract] [Full Text] [Related]

  • 15. Percutaneous coronary interventions for coronary artery disease: the long and short of optimizing medical therapy.
    Jaumdally R, Lip GY, Varma C.
    Int J Clin Pract; 2005 Sep 15; 59(9):1070-81. PubMed ID: 16115184
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interventions to improve guideline compliance following coronary artery bypass grafting.
    Yam FK, Akers WS, Ferraris VA, Smith K, Ramaiah C, Camp P, Flynn JD.
    Surgery; 2006 Oct 15; 140(4):541-7; discussion 547-52. PubMed ID: 17011901
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
    Anselmino M, Malmberg K, Ohrvik J, Rydén L, Euro Heart Survey Investigators.
    Eur J Cardiovasc Prev Rehabil; 2008 Apr 15; 15(2):216-23. PubMed ID: 18391651
    [Abstract] [Full Text] [Related]

  • 20. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.
    Fidan D, Unal B, Critchley J, Capewell S.
    QJM; 2007 May 15; 100(5):277-89. PubMed ID: 17449875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.